Optimizatsiya vedeniya bol'nykh khronicheskim gepatitom V na ambulatornom etape


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article considers the epidemiology and principles of serological monitoring of chronic hepatitis B (CHB), features of diagnosis of this disease in outpatient settings, and its clinical picture. Approaches to optimization of management of chronic hepatitis B patients at the outpatient treatment stage including collaboration of various specialists and criteria for antiviral therapy are presented.

Full Text

Restricted Access

References

  1. Брико Н.И. Эпидемиология парентеральных гепатитов В и С // Бюлл. Вакцинация 2001. № 6. С. 26-32.
  2. Simonetti J, Bulkow L, McMahon BJ, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohor chronically infected with hepatitis B virus. Hepatology 2010;51:1531-37.
  3. Абдурахманов Д.Т. Хронический гепатит B и D. М., 2010.
  4. Liu J, Yang H-L, Lee M-H, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 2010;139:474-82.
  5. Брико Н.И. Методические основы оценки социально-экономической эффективности вакцинопрофилактики гепатита В // Медицинская кафедра. 2003. № 2. С. 53-54.
  6. Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007;45:1056-75.
  7. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009;49:S45-S55.
  8. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-92.
  9. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-62.
  10. Liu J, Yang H-L, Lee M-H, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a communitybased follow-up study. Gastroenterology 2010;139(2):474-82.
  11. Yuen MF, Wong DKH, Fung J, et al. HBsAg sero-clearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008;135:1192-99.
  12. Brunetto MR, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009;49:1141-50.
  13. Keeffe EB, Dieterich DT, Han SHB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315-41.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies